Experimental method for modeling polycystic ovary syndrome in rats: a cross-sectional study
Russian Medicine · 05.07.2026 · 32 (3) · 220-229
DOI: 10.17816/medjrf702631 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Russian Medicine, online erschienen am 05.07.2026. Verfasst von Denis A. Borozdenko und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Existing rodent models of polycystic ovary syndrome (PCOS) have several limitations: they do not match the hormonal profile of the human disease, do not fully reproduce metabolic disturbances, or are difficult to implement. This study describes a PCOS modeling methodology suitable for preclinical research. AIM: To validate an experimental model of polycystic ovary syndrome in rats with the assessment of hormonal and histological parameters. METHODS: The animals were divided into three groups: intact (n = 22, saline), PCOS model (n = 30), and PCOS + therapy model (n = 10, pathology induction + combined oral contraceptives [COCs]). PCOS modeling was carried out for 10 days via intramuscular injections of human chorionic gonadotropin (300 U/animal) and increasing doses of isophane insulin (from 1.5 to 3.5 U/animal). The PCOS + therapy group received COCs (drospirenone + ethinyl estradiol) orally for 14 days. Body weight dynamics and glucose levels were measured as indicators of metabolic disorders. Hormone levels, including anti-Müllerian hormone (AMH), follicle-stimulating hormone (FSH), estradiol, and sex hormone-binding globulin (SHBG) were measured by ELISA. Morphological analysis was also performed. RESULTS: In modeling the pathology, PCOS model group showed a significant increase in body weight (295.2 ± 20.2 g) compared with the intact group (267.3 ± 22.4 g; p 0.05) and the PCOS + therapy group (273.9 ± 18.5 g; p 0.05). In the PCOS model group, levels of free testosterone, AMH, and estradiol increased, while SHBG decreased compared with the intact group (p 0.05). The LH/FSH ratio on day 12 was significantly higher in the PCOS + therapy group (16.6 ± 7.6) than the intact group (6.9 ± 4.8; p 0.05). Histological examination confirmed an increase in the number of cysts, atretic follicles, and corpora lutea in the ovaries of animals with induced PCOS. COCs therapy significantly reduced ovarian mass coefficients and glucose levels compared with the PCOS model group. CONCLUSION: The presented PCOS model, based on the combined administration of hCG and insulin in Wistar rats, successfully reproduces the key features of the disease: an increased LH/FSH ratio, hyperandrogenemia, elevated AMH and estradiol, decreased SHBG, polycystic ovarian morphology with multiple functional and retention cysts, and metabolic disorders such as weight gain. Furthermore, the model demonstrates sensitivity to standard COCs therapy.
Zitieren
APA
Borozdenko, D. A., Stislavskaya, S. A., Pyrkova, O. V., & Lyakhmun, D. N. (2026). Experimental method for modeling polycystic ovary syndrome in rats: a cross-sectional study. Russian Medicine, 32(3), 220-229. https://doi.org/10.17816/medjrf702631
Vancouver
Borozdenko DA, Stislavskaya SA, Pyrkova OV, Lyakhmun DN. Experimental method for modeling polycystic ovary syndrome in rats: a cross-sectional study. Russian Medicine. 2026;32(3):220-229. doi:10.17816/medjrf702631
BibTeX
@article{Borozdenko2026,
author = {Borozdenko, Denis A. and Stislavskaya, Sofya A. and Pyrkova, Oksana V. and Lyakhmun, Dmitriy N.},
title = {Experimental method for modeling polycystic ovary syndrome in rats: a cross-sectional study},
journal = {Russian Medicine},
year = {2026},
volume = {32},
number = {3},
pages = {220--229},
doi = {10.17816/medjrf702631}
}
EUVIMED